• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯并咪唑衍生物与镉的新型配位化合物的设计、合成与表征

Design, Synthesis, and Characterization of Novel Coordination Compounds of Benzimidazole Derivatives with Cadmium.

作者信息

Raducka Anita, Świątkowski Marcin, Korona-Głowniak Izabela, Kaproń Barbara, Plech Tomasz, Szczesio Małgorzata, Gobis Katarzyna, Czylkowska Agnieszka

机构信息

Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, Żeromskiego 116, 90-924 Łódź, Poland.

Department of Pharmaceutical Microbiology, Medical University of Lublin, Chodźki 1, 20-093 Lublin, Poland.

出版信息

Pharmaceutics. 2022 Aug 3;14(8):1626. doi: 10.3390/pharmaceutics14081626.

DOI:10.3390/pharmaceutics14081626
PMID:36015252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9412362/
Abstract

Four complexes of Cd(II) with benzimidazole derivatives were synthesized and named C1, C2, C3, and C4. All coordination compounds were characterized through elemental analysis (EA), flame atomic absorption spectrometry (FAAS), Fourier-transform infrared spectroscopy (FTIR), thermogravimetric analysis coupled with mass spectrometry) (TG-MS), a cytotoxicity assay (MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide)), and computational chemical analysis for absorption, distribution, metabolism, and excretion (ADME). All of the obtained results are compatible and are consistent with the respective structures of the obtained compounds and their properties. The various techniques used allowed the determination of the composition, proposed structure of the compounds, their thermal stability and thermal properties, and the method of coordination between the metal (II) ion and the ligand. The ADME technique was also used to estimate the physicochemical and biological properties. The antitumor activity of the compounds was determined with an MTT assay on the glioblastoma (T98G), neuroblastoma (SK-N-AS), and lung adenocarcinoma (A549) cell lines, as well as normal human skin fibroblasts (CCD-1059Sk). Compound C2 was found to have potential antitumor properties and to be effective in inhibiting the growth of neuroblastoma cells. The antimicrobial activity of Cd complexes, free ligands, and reference drugs was tested against six strains of Gram-positive bacteria, five strains of Gram-negative rods, and three strains of yeasts. Compound C3 significantly increased activity against Gram-positive bacteria in comparison to the ligand.

摘要

合成了四种镉(II)与苯并咪唑衍生物的配合物,分别命名为C1、C2、C3和C4。所有配位化合物均通过元素分析(EA)、火焰原子吸收光谱法(FAAS)、傅里叶变换红外光谱法(FTIR)、热重分析联用质谱法(TG-MS)、细胞毒性测定(MTT(3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐))以及吸收、分布、代谢和排泄(ADME)的计算化学分析进行了表征。所有获得的结果相互兼容,与所得到化合物的各自结构及其性质一致。所使用的各种技术能够确定化合物的组成、推测结构、热稳定性和热性质,以及金属(II)离子与配体之间的配位方式。ADME技术还用于评估物理化学和生物学性质。通过MTT法在胶质母细胞瘤(T98G)、神经母细胞瘤(SK-N-AS)、肺腺癌(A549)细胞系以及正常人皮肤成纤维细胞(CCD-1059Sk)上测定了化合物的抗肿瘤活性。发现化合物C2具有潜在的抗肿瘤特性,并且在抑制神经母细胞瘤细胞生长方面有效。测试了镉配合物、游离配体和参考药物对六种革兰氏阳性菌、五种革兰氏阴性杆菌和三种酵母菌株的抗菌活性。与配体相比,化合物C3对革兰氏阳性菌的活性显著增强。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/d1fd73272dae/pharmaceutics-14-01626-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/bf21dbb58477/pharmaceutics-14-01626-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/fe14a6f036c1/pharmaceutics-14-01626-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/1eca94401e53/pharmaceutics-14-01626-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/73b1525181e9/pharmaceutics-14-01626-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/23f9852fe1a2/pharmaceutics-14-01626-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/8222e476617b/pharmaceutics-14-01626-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/d4727a5ee28a/pharmaceutics-14-01626-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/62e3beea0dce/pharmaceutics-14-01626-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/d1fd73272dae/pharmaceutics-14-01626-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/bf21dbb58477/pharmaceutics-14-01626-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/fe14a6f036c1/pharmaceutics-14-01626-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/1eca94401e53/pharmaceutics-14-01626-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/73b1525181e9/pharmaceutics-14-01626-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/23f9852fe1a2/pharmaceutics-14-01626-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/8222e476617b/pharmaceutics-14-01626-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/d4727a5ee28a/pharmaceutics-14-01626-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/62e3beea0dce/pharmaceutics-14-01626-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0ca/9412362/d1fd73272dae/pharmaceutics-14-01626-g006.jpg

相似文献

1
Design, Synthesis, and Characterization of Novel Coordination Compounds of Benzimidazole Derivatives with Cadmium.苯并咪唑衍生物与镉的新型配位化合物的设计、合成与表征
Pharmaceutics. 2022 Aug 3;14(8):1626. doi: 10.3390/pharmaceutics14081626.
2
Zinc Coordination Compounds with Benzimidazole Derivatives: Synthesis, Structure, Antimicrobial Activity and Potential Anticancer Application.锌配合物与苯并咪唑衍生物:合成、结构、抗菌活性及潜在抗癌应用。
Int J Mol Sci. 2022 Jun 13;23(12):6595. doi: 10.3390/ijms23126595.
3
Copper(II) Complexes with 1-(Isoquinolin-3-yl)heteroalkyl-2-ones: Synthesis, Structure and Evaluation of Anticancer, Antimicrobial and Antioxidant Potential.铜(II)配合物与 1-(异喹啉-3-基)杂环烷基-2-酮:合成、结构及抗癌、抗菌和抗氧化潜力评价。
Int J Mol Sci. 2023 Dec 19;25(1):8. doi: 10.3390/ijms25010008.
4
Characterization of Metal-Bound Benzimidazole Derivatives, Effects on Tumor Cells of Lung Cancer.金属结合苯并咪唑衍生物的表征及其对肺癌肿瘤细胞的影响
Materials (Basel). 2021 May 30;14(11):2958. doi: 10.3390/ma14112958.
5
In Silico ADME and Toxicity Prediction of Benzimidazole Derivatives and Its Cobalt Coordination Compounds. Synthesis, Characterization and Crystal Structure.苯并咪唑衍生物及其钴配合物的计算机辅助 ADME 和毒性预测。合成、表征和晶体结构。
Molecules. 2022 Nov 18;27(22):8011. doi: 10.3390/molecules27228011.
6
Anticancer and antimicrobial activity of new copper (II) complexes.新型铜(II)配合物的抗癌和抗菌活性
J Inorg Biochem. 2023 Mar;240:112108. doi: 10.1016/j.jinorgbio.2022.112108. Epub 2022 Dec 17.
7
Transition Metal Complexes with Flufenamic Acid for Pharmaceutical Applications-A Novel Three-Centered Coordination Polymer of Mn(II) Flufenamate.用于药物应用的含氟芬那酸过渡金属配合物——一种新型的氟芬那酸锰(II)三中心配位聚合物
Materials (Basel). 2020 Aug 21;13(17):3705. doi: 10.3390/ma13173705.
8
Antitumor Activity and Physicochemical Properties of New Thiosemicarbazide Derivative and Its Co(II), Ni(II), Cu(II), Zn(II) and Cd(II) Complexes.新型硫代卡巴肼衍生物及其 Co(II)、Ni(II)、Cu(II)、Zn(II)和 Cd(II)配合物的抗肿瘤活性和物理化学性质。
Molecules. 2022 Apr 22;27(9):2703. doi: 10.3390/molecules27092703.
9
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.铁(II)、锌(II)、镉(II)和汞(II)与2,6-双(苯并咪唑-2-基)吡啶配体配合物的合成、表征及抗菌活性
Eur J Med Chem. 2007 Feb;42(2):205-13. doi: 10.1016/j.ejmech.2006.09.023. Epub 2006 Dec 26.
10
New Coordination Compounds Based on a Pyrazine Derivative: Design, Characterization, and Biological Study.基于吡嗪衍生物的新型配位化合物:设计、表征和生物学研究。
Molecules. 2022 May 27;27(11):3467. doi: 10.3390/molecules27113467.

引用本文的文献

1
Novel Fluorescent Benzimidazole-Hydrazone-Loaded Micellar Carriers for Controlled Release: Impact on Cell Toxicity, Nuclear and Microtubule Alterations in Breast Cancer Cells.用于控释的新型荧光苯并咪唑腙负载胶束载体:对乳腺癌细胞的细胞毒性、细胞核和微管改变的影响
Pharmaceutics. 2023 Jun 16;15(6):1753. doi: 10.3390/pharmaceutics15061753.
2
In Silico ADME and Toxicity Prediction of Benzimidazole Derivatives and Its Cobalt Coordination Compounds. Synthesis, Characterization and Crystal Structure.苯并咪唑衍生物及其钴配合物的计算机辅助 ADME 和毒性预测。合成、表征和晶体结构。
Molecules. 2022 Nov 18;27(22):8011. doi: 10.3390/molecules27228011.

本文引用的文献

1
Zinc Coordination Compounds with Benzimidazole Derivatives: Synthesis, Structure, Antimicrobial Activity and Potential Anticancer Application.锌配合物与苯并咪唑衍生物:合成、结构、抗菌活性及潜在抗癌应用。
Int J Mol Sci. 2022 Jun 13;23(12):6595. doi: 10.3390/ijms23126595.
2
Characterization of Metal-Bound Benzimidazole Derivatives, Effects on Tumor Cells of Lung Cancer.金属结合苯并咪唑衍生物的表征及其对肺癌肿瘤细胞的影响
Materials (Basel). 2021 May 30;14(11):2958. doi: 10.3390/ma14112958.
3
Copper Coordination Compounds as Biologically Active Agents.
铜配合物作为生物活性试剂。
Int J Mol Sci. 2020 May 31;21(11):3965. doi: 10.3390/ijms21113965.
4
Zn(ii), Cd(ii) and Hg(ii) saccharinate complexes with 2,6-bis(2-benzimidazolyl)pyridine as promising anticancer agents in breast and lung cancer cell lines via ROS-induced apoptosis.Zn(ii)、Cd(ii) 和 Hg(ii) 与 2,6-二(2-苯并咪唑基)吡啶的 saccharinate 配合物作为有前途的抗癌剂,通过 ROS 诱导的细胞凋亡作用于乳腺癌和肺癌细胞系。
Dalton Trans. 2020 Jun 16;49(23):7842-7851. doi: 10.1039/d0dt01535k.
5
H-Bonded and metal(ii)-organic architectures assembled from an unexplored aromatic tricarboxylic acid: structural variety and functional properties.由一种未被探索的芳香族三羧酸组装而成的氢键和金属(II)有机结构:结构多样性和功能特性
Dalton Trans. 2020 Jun 2;49(21):7197-7209. doi: 10.1039/d0dt01261k.
6
Cd -Organic Frameworks Fabricated with a N-Rich Ligand and Flexible Dicarboxylates: Structural Diversity and Multi-Responsive Luminescent Sensing for Toxic Anions and Ethylenediamine.Cd-有机骨架的富氮配体和柔性二羧酸构建:结构多样性及对有毒阴离子和乙二胺的多重响应发光传感
Chem Asian J. 2019 Dec 2;14(23):4420-4428. doi: 10.1002/asia.201901489. Epub 2019 Nov 28.
7
New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment.顺铂耐药机制的新见解:从肿瘤细胞到微环境。
Int J Mol Sci. 2019 Aug 24;20(17):4136. doi: 10.3390/ijms20174136.
8
Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells.具有碘代苯甲酸部分的新型四氢吖啶衍生物诱导 A549 非小细胞肺癌和 HT-29 结肠癌细胞的 G0/G1 细胞周期停滞和细胞凋亡。
Mol Cell Biochem. 2019 Oct;460(1-2):123-150. doi: 10.1007/s11010-019-03576-x. Epub 2019 Jul 16.
9
Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview.基于纳米技术的新型药物输送系统在设计顺铂治疗癌症方面的最新进展:综述。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1674-1692. doi: 10.1080/21691401.2019.1604535.
10
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.帕博利珠单抗对比化疗用于未经治疗、PD-L1 表达、局部晚期或转移性非小细胞肺癌(KEYNOTE-042):一项随机、开放标签、对照、III 期临床试验。
Lancet. 2019 May 4;393(10183):1819-1830. doi: 10.1016/S0140-6736(18)32409-7. Epub 2019 Apr 4.